During the first 3 months of pregnancy and during lactation; Patients known to be sensitive or hypersensitive to nitroimidazoles; Organic neurological disorders (CNS disorders); Blood dyscrasias or other anomalies of the blood picture; Concurrent use of ethyl alcohol; Severe hepatic failure.